Want to see DE:AAQ1 full AI Analyst Report?
Total Valuation
aap Implantate has a market cap or net worth of €23.25M. The enterprise value is €27.65M.
Market Cap€23.25M
Enterprise Value€27.65M
Share Statistics
aap Implantate has 14,716,976 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,716,976
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
aap Implantate’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee126.26K
Profits Per Employee-26.11K
Employee Count99
Asset Turnover0.91
Inventory Turnover0.43
Valuation Ratios
The current PE Ratio of aap Implantate is ―. aap Implantate’s PEG ratio is 0.15.
PE Ratio―
PS Ratio1.58
PB Ratio2.27
Price to Fair Value2.27
Price to FCF-9.15
Price to Operating Cash Flow-15.58
PEG Ratio0.15
Income Statement
In the last 12 months, aap Implantate had revenue of 12.50M and earned -2.60M in profits. Earnings per share was -0.19.
Revenue12.50M
Gross Profit10.80M
Operating Income-2.50M
Pretax Income0.00
Net Income-2.60M
EBITDA-2.50M
Earnings Per Share (EPS)-0.19
Cash Flow
In the last 12 months, operating cash flow was -1.43M and capital expenditures -406.00K, giving a free cash flow of -1.84M billion.
Operating Cash Flow-1.43M
Free Cash Flow-1.84M
Free Cash Flow per Share-0.13
Dividends & Yields
aap Implantate pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.13
52-Week Price Change6.54%
50-Day Moving Average1.73
200-Day Moving Average1.59
Relative Strength Index (RSI)36.28
Average Volume (3m)620.00
Important Dates
aap Implantate upcoming earnings date is Aug 17, 2026, TBA (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
aap Implantate as a current ratio of 2.07, with Debt / Equity ratio of 11.32%
Current Ratio2.07
Quick Ratio1.04
Debt to Market Cap0.01
Net Debt to EBITDA-0.13
Interest Coverage Ratio0.00
Taxes
In the past 12 months, aap Implantate has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
aap Implantate EV to EBITDA ratio is -8.03, with an EV/FCF ratio of -9.30.
EV to Sales1.61
EV to EBITDA-8.03
EV to Free Cash Flow-9.30
EV to Operating Cash Flow-14.00
Balance Sheet
aap Implantate has €1.40M in cash and marketable securities with €984.00K in debt, giving a net cash position of €419.00K billion.
Cash & Marketable Securities€1.40M
Total Debt€984.00K
Net Cash€419.00K
Net Cash Per Share€0.03
Tangible Book Value Per Share€0.48
Margins
Gross margin is 82.25%, with operating margin of -20.00%, and net profit margin of -20.80%.
Gross Margin82.25%
Operating Margin-20.00%
Pretax Margin0.00%
Net Profit Margin-20.80%
EBITDA Margin-20.00%
EBIT Margin-20.00%
Analyst Forecast
The average price target for aap Implantate is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.43%
EPS Growth Forecast47.08%